/
/
Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Chapters
- 00:05Title
- 01:40Transfection of Recombinant CAV2 Genomic Plasmid onto DK-E1 Cells
- 03:25Propagation of Recombinant CAV2
- 05:48Large-scale CAV2 Purification
- 10:07Titration of CAV2 by End-point Dilution
- 11:04Results: Production, Purification, and Application of CAV2
- 14:04Conclusion
These past 15 years, canine adenovirus type 2 (CAV2)-derived vectors have proven their efficiency to transduce cells in vitro and in vivo and are widely used for vaccination and gene therapy. Here, we describe a procedure to construct, produce and purify CAV2 vectors, giving rise to high-titer viral suspensions.
